@the_news_21
Adar Poonawalla, chief executive officer (CEO), Serum Institute of India in an interview with The Mint has said that a coronavirus vaccine is likely to come in India by January 2021. “Based on the success of the trials in India and the United Kingdom, and if approvals from regulatory bodies are in place in time, then we can expect the vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious,” Poonawalla told the Mint.
Serum Institute of India has been in the spotlight for the past few months as it is to manufacture the coronavirus vaccine developed by Oxford University and AstraZeneca in India. It began trials in the country in August-end and in last week of September, the third phase of human clinical trial began at the state-run Sassoon General Hospital in Pune.
Poonawalla also said that Serum Institute is in talks with the government over the pricing of the vaccine, ensuring that it will be made available at an affordable price. “We are certain that it will be affordable for all,” he added.
